Pharmafile Logo
Pharmafocus logo
Advanced Search

Diurnal

Showing 2 posts of 2 posts found.

Diurnal and Citrine sign licensing agreement for Alkindi

January 27, 2021
Research and Development Citrine, Diurnal

Diurnal Group has entered into an exclusive licence agreement for its product Alkindi (hydrocortisone granules in capsules for opening) with …

News
turkey_flag

Diurnal joins Er-Kim to distribute cortisol deficiency treatments in Turkey

January 13, 2021
Research and Development Diurnal, Diurnal Group, Er-Kim, Turkey

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024